Hypoxia/reoxygenation: A dynamic regulator of lysyl oxidase-facilitated breast cancer migration

Journal of Cellular Biochemistry

Volumn 103, Issue 5, 2008, Pages 1369-1378

  Postovit, Lynne Marie ^a   Abbott, Daniel E ^a   Payne, Stacey L ^a,d   Wheaton, William W ^a   Margaryan, Naira V ^a   Sullivan, Richard ^b   Jansen, Matthias K ^c   Csiszar, Katalin ^c   Hendrix, Mary J C ^a   Kirschmann, Dawn A ^a,e  

^a NORTHWESTERN UNIVERSITY   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF HAWAII   (United States)

^d ELMHURST COLLEGE   (United States)

^e CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

Author keywords

Breast cancer; Hypoxia; Lysyl oxidase; Motility; Reoxygenation

Indexed keywords

3 AMINOPROPIONITRILE; FOCAL ADHESION KINASE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROTEIN LYSINE 6 OXIDASE; PROTEIN TYROSINE KINASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CARCINOMA IN SITU; CATALYSIS; CELL HYPOXIA; CELL MIGRATION; ELECTROPHORESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REOXYGENATION; UPREGULATION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN PEROXIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROTEIN-LYSINE 6-OXIDASE;

EID: 41749124983     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21517     Document Type: Article

References (31)

1. Anderson ARA, Weaver AM, Cummings PT, Quaranta V. 2006. Tumor morphology and phenotypic evolution driven by selective pressure from the microenvironment. Cell 127:905-915.
2. Bouez C, Reynaud C, Noblesse E, Thepot A, Gleyzal C, Kanitakis J, Perrier E, Damour O, Sommer P. 2006. The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model. Clin Cancer Res 12:1463-1469.
3. Cairns RA, Hill RP. 2004. Acute hypoxia enhances spontaneous lymph node metastasis in an orthotopic murine model of human cervical carcinoma. Cancer Res 64:2054-2061.
4. Erler JT, Bennewith KL, Nicolau M, Dornhofer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. 2006. Lysyl oxidase is essential for hypoxia-induced metastasis. Nature 440:1222-1226.
5. Fogelgren B, Polgar N, Szauter KM, Ujfaludi Z, Laczko R, Fong KS, Csiszar K. 2005. Cellular fibronectin binds to lysyl oxidase with high affinity and is critical for its proteolytic activation. J Biol Chem 280:24690-24697.
6. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
7. Hussain SA, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J, Murray PG, Perunovic B, Anwar MS, Billingham L, James ND, Spooner D, Poole CJ, Rea DW, Palmer DH. 2007. Hypoxia-regulated carbonic anhydrase IX expression in associated with poor survival in patients with invasive breast cancer. Br J Cancer 96:104-109.
8. Jansen MK, Csiszar K. 2007. Intracellular localization of the matrix enzyme lysyl oxidase in polarized epithelial cells. Matrix Biol 26:136-139.
9. Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ. 2002. A molecular role for lysyl oxidase in breast cancer invasion. Cancer Res 62:4478-4483.
10. Li PA, He Q, Cao T, Yong G, Szauter KM, Fong KS, Karlsson J, Keep MF, Csiszar K. 2004. Up-regulation and altered distribution of lysyl oxidase in the central nervous system of mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis. Brain Res Mol Brain Res 120:115-122.
11. Lucero H, Kagan HM. 2006. Lysyl oxidase: an oxidative enzyme and effector of cell function. Cell Mol Life Sci 63:2304-2316.
12. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, Ratcliffe PJ. 1999. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271-275.
13. Min C, Kirsch KH, Zhao Y, Jeay S, Palamakumbura AH, Trackman PC, Sonenshein GE. 2007. The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2/neu-driven breast cancer. Cancer Res 67:1105-1112.
14. Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver WM. 2005. Tensional homeostasis and the malignant phenotype. Cancer Cell 8:241-254.
15. Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA. 2005. Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism. Cancer Res 65:11429-11436.
16. Cas/Crk/DOCK180 signaling complex. J Cell Biochem 98:827-837.
17. Payne SL, Hendrix MJC, Kirschmann DA. 2007. Paradoxical roles for lysyl oxidases in cancer - a prospect. J Cell Biochem 101:1338-1354.
18. Polgar N, Fogelgren B, Shipley JM, Csiszar K. 2007. Lysyl oxidase interacts with hormone placental lactogen and synergistically promotes breast epithelial cell proliferation and migration. J Biol Chem 282:3262-3272.
19. Postovit LM, Adams MA, Lash GE, Heaton JP, Graham CH. 2002. Oxygen-mediated regulation of tumor cell invasiveness. Involvement of a nitric oxide signaling pathway. J Biol Chem 277:35730-35737.
20. Pouyssegur J, Dayan F, Mazure NM. 2006. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature 441:437-443.
21. Rinker-Schaeffer CW, O'Keefe JP, Welch DR, Theodorescu D. 2006. Metastasis suppressor proteins: Discovery, molecular mechanisms, and clinical application. Clin Cancer Res 12:3882-3889.
22. Rofstad EK. 2000. Microenvironment-induced cancer metastasis. Int J Radiat Biol 76:589-605.
23. Rofstad EK, Galappathi K, Mathiesen B, Ruud EBM. 2007. Fluctuating and diffusion-limited hypoxia in hypoxia-induced metastasis. Clin Cancer Res 13:1971-1978.
24. Seko Y, Takahashi N, Sabe H, Tobe K, Kadowaki T, Nagai R. 1999. Hypoxia induces activation and subcellular translocation of focal adhesion kinase (p1259FAK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun 262:290-296.
25. Semenza GL. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 12:925-932.
26. Semenza GL, Agani F, Feldser D, Iyer N, Kotch L, Laughner E, Yu A. 2000. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv Exp Med Biol 475:123-130.
27. Siesser PMF, Hanks SK. 2006. The signaling and biological implications of FAK overexpression in cancer. Clin Cancer Res 12:3233-3237.
28. Steeg PS. 2006. Tumor metastasis: Mechanistic insights and clinical challenges. Nat Med 12:895-903.
29. Subarsky P, Hill RP. 2003. The hypoxic tumour microenvironment and metastatic progression. Clin Exp Met 20:237-250.
30. Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J, Hendrix MJ. 2006. Embryonic and tumorigenic pathways converge via Nodal signaling: Role in melanoma aggressiveness. Nat Med 12:925-932.
31. Wood CS, Koepke JI, Teng H, Boucher KK, Katz S, Chang P, Terlecky LJ, Papanayotou I, Walton PA, Terlecky SR. 2006. Hypocatalasemic fibroblasts accumulate hydrogen peroxide and display age-associated pathologies. Traffic 7:97-107.